S&P 500   3,975.33 (+1.90%)
DOW   31,910.97 (+2.08%)
QQQ   292.50 (+1.32%)
AAPL   142.41 (+3.50%)
MSFT   259.91 (+2.91%)
FB   194.50 (+0.50%)
GOOGL   2,225.25 (+2.16%)
AMZN   2,125.98 (-1.20%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.41 (-0.44%)
NIO   15.70 (-4.50%)
AMD   94.11 (+0.65%)
CGC   5.13 (-7.07%)
MU   69.33 (+0.62%)
T   20.88 (+2.35%)
GE   75.93 (+0.90%)
F   12.84 (+2.72%)
DIS   104.89 (+2.41%)
AMC   11.62 (-3.41%)
PFE   53.06 (+1.12%)
PYPL   80.75 (+0.26%)
NFLX   184.61 (-0.93%)
S&P 500   3,975.33 (+1.90%)
DOW   31,910.97 (+2.08%)
QQQ   292.50 (+1.32%)
AAPL   142.41 (+3.50%)
MSFT   259.91 (+2.91%)
FB   194.50 (+0.50%)
GOOGL   2,225.25 (+2.16%)
AMZN   2,125.98 (-1.20%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.41 (-0.44%)
NIO   15.70 (-4.50%)
AMD   94.11 (+0.65%)
CGC   5.13 (-7.07%)
MU   69.33 (+0.62%)
T   20.88 (+2.35%)
GE   75.93 (+0.90%)
F   12.84 (+2.72%)
DIS   104.89 (+2.41%)
AMC   11.62 (-3.41%)
PFE   53.06 (+1.12%)
PYPL   80.75 (+0.26%)
NFLX   184.61 (-0.93%)
S&P 500   3,975.33 (+1.90%)
DOW   31,910.97 (+2.08%)
QQQ   292.50 (+1.32%)
AAPL   142.41 (+3.50%)
MSFT   259.91 (+2.91%)
FB   194.50 (+0.50%)
GOOGL   2,225.25 (+2.16%)
AMZN   2,125.98 (-1.20%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.41 (-0.44%)
NIO   15.70 (-4.50%)
AMD   94.11 (+0.65%)
CGC   5.13 (-7.07%)
MU   69.33 (+0.62%)
T   20.88 (+2.35%)
GE   75.93 (+0.90%)
F   12.84 (+2.72%)
DIS   104.89 (+2.41%)
AMC   11.62 (-3.41%)
PFE   53.06 (+1.12%)
PYPL   80.75 (+0.26%)
NFLX   184.61 (-0.93%)
S&P 500   3,975.33 (+1.90%)
DOW   31,910.97 (+2.08%)
QQQ   292.50 (+1.32%)
AAPL   142.41 (+3.50%)
MSFT   259.91 (+2.91%)
FB   194.50 (+0.50%)
GOOGL   2,225.25 (+2.16%)
AMZN   2,125.98 (-1.20%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.41 (-0.44%)
NIO   15.70 (-4.50%)
AMD   94.11 (+0.65%)
CGC   5.13 (-7.07%)
MU   69.33 (+0.62%)
T   20.88 (+2.35%)
GE   75.93 (+0.90%)
F   12.84 (+2.72%)
DIS   104.89 (+2.41%)
AMC   11.62 (-3.41%)
PFE   53.06 (+1.12%)
PYPL   80.75 (+0.26%)
NFLX   184.61 (-0.93%)
LON:SPH

Sinclair Pharma (SPH) Share Forecast, Price & News

GBX 31.80
0.00 (0.00%)
(As of 11/5/2018)
Add
Compare
Today's Range
31.80
31.80
50-Day Range
31.80
31.80
52-Week Range
14.45
32
Volume
373,221 shs
Average Volume
3.30 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive SPH News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinclair Pharma and its competitors with MarketBeat's FREE daily newsletter.

Sinclair Pharma logo

About Sinclair Pharma

Sinclair Pharma plc, a specialty pharmaceutical company, engages in the manufacture, commercialization, and sale of dermatological products worldwide. It provides Silhouette Soft, a resorbable poly-L-lactic acid(PLLA)/PLGA suture with bi-directional resorbable cones for skin repositioning and tightening; and Ellansé, which offers dermal fillers. The company also provides Perfectha for wrinkle correction, facial contouring, and volume restoration; and Sculptra designed to stimulate collagen growth. It serves healthcare providers and plastic surgeons. The company was formerly known as Sinclair IS Pharma plc and changed its name to Sinclair Pharma plc in December 2015. Sinclair Pharma plc was founded in 1971 and is headquartered in London, the United Kingdom.

Headlines

Sinclair Pharma Share Chat
(LSE:ACHL)
LiveLeak's reign of gory terror is over after 15 years
See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Optionable

MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Sinclair Pharma (LON:SPH) Frequently Asked Questions

Who are Sinclair Pharma's key executives?
Sinclair Pharma's management team includes the following people:
  • Mr. Christopher P. Spooner, CEO & Exec. Director
  • Mr. Alan Musgrave Olby, CFO & Director (Age 47)
  • Ms. Jayne Burrell, Group Gen. Counsel & Company Sec. (Age 43)
  • Ms. Emilie Croissant, Head of Europe & Global Marketing
  • Mr. Nairn McMaster, Head of Latin America
What other stocks do shareholders of Sinclair Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sinclair Pharma investors own include Vectura Group (VEC), Energy Transfer (ET), Hikma Pharmaceuticals (HIK), (ARYN), ASOS (ASC), Bayer Aktiengesellschaft (BAYN), Cracker Barrel Old Country Store (CBRL), (CELG), (CLN) and Jack in the Box (JACK).

What is Sinclair Pharma's stock symbol?

Sinclair Pharma trades on the London Stock Exchange (LON) under the ticker symbol "SPH."

How do I buy shares of Sinclair Pharma?

Shares of SPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Sinclair Pharma's stock price today?

One share of SPH stock can currently be purchased for approximately GBX 31.80.

How many employees does Sinclair Pharma have?

Sinclair Pharma employs 2,021 workers across the globe.

What is Sinclair Pharma's official website?

The official website for Sinclair Pharma is www.sinclairispharma.com.

How can I contact Sinclair Pharma?

Sinclair Pharma's mailing address is 1st Fl Whitfield Court, 30-32 Whitfield Street, LONDON, W1T 2RQ, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-20-74676920.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.